Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Summary
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Description from CNBC.
Who is covering this
-
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
Comments
Comments need JavaScript.